SENTRY study: using blood platelets to detect ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at changes in blood platelets to see if they can help detect ovarian cancer earlier. It is for women who have a new ovarian or pelvic mass and are about to have a biopsy or surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 21 or older.
- You have been diagnosed with an ovarian or pelvic mass (lump).
- You have not yet received any treatment for ovarian cancer (if it is cancer).
- Your doctor plans to do a biopsy or surgery to look at the mass.
- You do not have any other active cancer (except certain skin cancers or early cervical changes).
- You can give a blood sample.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test to help find ovarian cancer early in women who are at average risk. By joining, you may help improve early detection, which could lead to better outcomes.
This trial studies whether a simple blood test (liquid biopsy) can help tell if an ovarian mass is cancer or not, and if it can catch cancer early. If you're going to have surgery for a suspicious ovarian mass, this test might give extra information to guide your care.
This study is testing new blood tests that might help detect ovarian cancer earlier by looking for specific markers. It involves people with suspected ovarian cancer and healthy volunteers, and aims to improve how we diagnose the disease.
This study is testing a blood test to see if it can catch ovarian cancer early. You may be eligible if you have been recently diagnosed with ovarian cancer and haven't started treatment yet.
This study is testing a new blood test (called the EARLY panel) to see how well it can detect ovarian cancer in postmenopausal women aged 50–74. It aims to find out if the test is accurate and practical for routine screening.
This study is testing whether a simple blood test can predict the risk of ovarian cancer coming back after treatment. It might help doctors decide who needs more aggressive therapy.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.